Real-time enrollment status for this idh wildtype glioblastoma clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 11:14 PM UTC
| NCT Number | NCT07089641 |
| Recruiting Status | Recruiting |
| Condition | IDH Wildtype Glioblastoma |
| Phase | PHASE1 |
| Target Enrollment | 50 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Jonsson Comprehensive Cancer Center |
| Last Updated on CT.gov | September 18, 2026 (Sep 18, 2026) |
As of October 18, 2026: Clinical trial NCT07089641 is currently recruiting participants. This phase1 study for idh wildtype glioblastoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Jonsson Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07089641 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07089641 was last updated Sep 18, 2026 (September 18, 2026). HelloStudys verifies this status automatically.